Schedule & Agenda
Monday, June 5
6:30 AM - 6:00 PM
9:00 AM - 12:00 PM
The Department of Defense (DoD) is continuously engaging in efforts to protect the warfighter from…
10:00 AM - 11:00 AM
Asia-Pacific populations share many concerns with the rest of the world, from aging populations to…
11:00 AM - 12:00 PM
In the last 10 years, APAC has become a hotspot for clinical trials: the region contributed almost…
12:00 PM - 1:00 PM
Asia Pacific is home to 60% of the world population, 35% of the global GDP and 5 out of the top 15…
12:00 PM - 6:00 PM
Exhibition Floor
12:30 PM - 5:30 PM
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1…
Session Rooms 103-104C
12:30 PM - 12:45 PM
Praetego is biopharma company developing first-in-class Advanced Glycation End-product (AGE)…
Session Room 104C
QBiotics is a public unlisted Australian life sciences company that discovers and develops new…
Session Room 103
• 2nd-largest and vertically-integrated pharma company in China ~ $35B revenue in 2022 across…
Session Room 104B
STALICLA is a clinical stage, precision molecular neuroscience biotech company with a mature…
Session Room 104A
Like in previous years, we plan to provide an update on the trends and key data from 2022 and an…
Session Room 102B
12:45 PM - 1:00 PM
Inimmune is a fast-moving innovative biotechnology company focused on the discovery and development…
Session Room 103
ModeX Therapeutics, an OPKO Health subsidiary, is a clinical-stage biopharmaceutical company…
Session Room 104B
Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to…
Session Room 104A
Starpax has developed a never before seen technology that guides in 3D Magnetodrones™ in tumors…
Session Room 104C
1:00 PM - 1:15 PM
Alphyn Biologics is clinical-stage developing first-in-class Multi-Target Therapeutics™ initially…
Session Room 104C
Glycostem is focused on the development of first and second generation stem cell-derived Natural…
Session Room 103
The Netherlands: Europe's connected Life Sciences & Health Metropolis. Life Sciences businesses in…
Session Room 102B
OculoTherapy is an early-stage start-up with a novel IOP-lowering eye drop for use in patients with…
Session Room 104B
Ordaōs is a human-enabled, machine-driven drug design company that creates novel and customized…
Session Room 104A
1:00 PM - 2:00 PM
The pharma industry is facing a wave of loss of exclusivity estimated at $200B through 2026 and an…
Although the COVID-19 pandemic has accelerated digital transformation, there are still varying…
This panel will discuss the next generation of digital therapeutics and the progress and promise of…
Targeted protein degradation (TPD) is a hot area of drug discovery aiming to expand the universe of…
Hear from biotech and pharma innovators who have created collaborations to turn technology…
To further exploit the full potential of real-world data (RWD) to generate evidence suitable to…
Session Room 204AB
This session will focus on pull incentives (e.g., the PASTEUR Act, BARDA procurements under Project…
The EU pharmaceutical landscape is experiencing its most significant transformation in over 20…
Join this special session for the launch of the inaugural BIO Film Festival. Hear from leading…
In the words of Eleanor Roosevelt, “A woman is like a teabag—you can’t tell how strong she is until…
1:00 PM - 5:00 PM
1:00 PM – 2:00 PM: Panel Discussion
2:00 PM – 5:00 PM: Film Screenings*
DISORDER Films:
•…
Session Room 105
1:15 PM - 1:30 PM
Biocytogen is a global biotechnology company that drives the research and development of novel…
Session Room 103
We are a clinical-stage biotechnology company dedicated to the discovery and development of…
Session Room 104C
NexThera Co., Ltd. is a biotech venture company that utilizes its recombinant protein-based…
Session Room 104B
Presentation by the Swiss Biotech Association and the Swiss Business Hub USA/Swiss Department of…
Session Room 102B
VerImmune Inc (www.verimmune.com) is a biotechnology company developing a novel Virus-inspired…
Session Room 104A
1:30 PM - 1:45 PM
Atreca is a clinical-stage biotech company inverting the traditional approach to cancer drug…
Session Room 103
The Belgian life sciences ecosystem
GOAL: present the strenghts of Belgium as a life sciences &…
Session Room 102B
CXL Ophthalmics (CXLO) is developing innovative treatments for corneal diseases with the goal of…
Session Room 104B
We are a global biotechnology company focused on further improving and leveraging the patented and…
Session Room 104A
RxMP Therapeutics, Inc. (“RxMP”) is an emerging, specialty therapeutics company focused on…
Session Room 104C
1:45 PM - 2:00 PM
AVEO Oncology, an LG Chem Company, is a commercial stage, oncology-focused biopharmaceutical…
Session Room 103
Bond Biosciences, Inc. is a privately held, clinical-stage biopharmaceutical company focused on the…
Session Room 104C
DeepCure is building a different kind of AI biotech company. DeepCure’s AI is harnessing the power…
Session Room 104A
Session Room 102B
Nicox is an international ophthalmology company developing innovative therapeutics to help maintain…
Session Room 104B
2:00 PM - 2:15 PM
BYOMass is a preclinical pharmaceutical company developing novel biologic and small molecule drugs…
Session Room 104C
Centivax’s mission is to accelerate the world’s transition to a post-pathogen humanity.
…
Session Room 104B
Glycan Therapeutics is a pioneer in design and synthesis of structurally homogeneous…
Session Room 104A
Mexico offers unique opportunities for investors, researchers, companies, and other countries and…
Session Room 102B
PharmAbcine Inc. is a clinical stage public company developing next generation antibody…
Session Room 103
2:15 PM - 2:30 PM
Aeolian Biotech is reaching for an improved pneumococcal vaccine. Our management team includes…
Session Room 104B
We are a clinical-stage biopharmaceutical company focused on developing novel synthetic lethality…
Session Room 104C
Privo Technologies, Inc. (Privo) is a phase 3 clinical-stage biopharmaceutical company committed to…
Session Room 103
Sibylla Biotech is an early-stage drug discovery company whose primary goal is the identification…
Session Room 104A
2:15 PM - 3:15 PM
Are you experiencing AI vertigo? The dizzying array of things AI can seemingly do--good, great, and…
Commissioner Califf has on numerous occasions noted combatting misinformation as a high priority…
This session will present strategies from CEOs who have secured major financings (AsherBio $108M…
The COVID-19 and Mpox health emergencies have underscored the need to be prepared to address future…
Join the discussion as to how we can address the healthcare challenges of today and tomorrow by…
In April 2022, FDA issued draft guidance on developing a Race and Ethnicity Diversity Plan to…
The market volatility in the last 18 months has made it difficult for public biopharmaceutical…
Is this the yearIs this the year that biotech IPO's recover? How do you know when to make the leap?…
The clinical development of advanced therapies often proceeds without a robust understanding of the…
Novel enabling technologies (ET) and therapies emerge at an ever-increasing speed across multiple…
2:30 PM - 2:45 PM
Blue Lake is a clinical stage company developing novel intranasal vaccines based on parainfluenza…
Session Room 104B
One carbon therapeutics is developing innovative therapeutics for oncology indications with high…
Session Room 103
Prazer Therapeutics is a Korean biotech company pioneering innovative small molecule therapeutics…
Session Room 104A
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform…
Session Room 104C
2:45 PM - 3:00 PM
CHA Vaccine Institute (CVI) is a clinical stage biopharmaceutical company developing proprietary…
Session Room 104C
Oxymo Technologies, a French-Canadian biotech, is developing Oximo, a topical drug product for the…
Session Room 104B
Predictive Oncology is a knowledge-driven company disrupting the oncology drug discovery paradigm…
Session Room 103
Founded in 2021, Serna Bio is building the first map of the druggable transcriptome, opening up the…
Session Room 104A
3:00 PM - 3:15 PM
Singapore is an emerging global biotech innovation hub, fostering groundbreaking advancements and…
Session Room 102B
FunPep is a public, late clinical-stage therapeutics company that has developed a functional…
Session Room 104A
Neuro-Innovators, LLC (NIV) is a clinical stage drug company. Its purpose, accelerate brain…
Session Room 103
Rejuvenate Biomed is an independent Belgian biomedical company established in October 2017 by Ann…
Session Room 104C
Vaxxas is developing and commercializing a high-density microarray patch (HD-MAP) as an alternative…
Session Room 104B
3:15 PM - 3:30 PM
We, Aprogen, Inc., are a listed company on the Korea Exchange (007460:KS) with over 20 years of…
Session Room 104C
Join leaders from the Australia biotechnology industry as they highlight Australia as a global…
Session Room 102B
CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique…
Session Room 104A
NanoViricides, Inc. is developing highly effective & safe antivirals acting by a novel mechanism of…
Session Room 104B
Reconnect Labs is a Swiss, clinical stage pharmaceutical company developing Regenerative…
Session Room 103
3:30 PM - 3:45 PM
Atamyo Therapeutics is a clinical-stage biopharma focused on the development of a new generation of…
Session Room 104B
Caszyme is a biotech company, based in Vilnius, Lithuania. The company specializes in development…
Session Room 104A
MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain…
Session Room 103
SymBio Pharmaceuticals Limited is a fully integrated, commercial-stage specialty pharmaceutical…
Session Room 104C
3:30 PM - 4:30 PM
Drug approval rates in biotech are dismal, with CNS proving to be a particularly challenging area…
In today’s turbulent market backdrop, both life science companies and investors are required to…
We will dive deep into the challenges faced by biotech companies in securing funding, particularly…
Life sciences and healthcare companies are increasingly leveraging AI, machine learning and data…
This will be a Fireside Chat with Jim Healy at Sofinnova Investments, moderated by Querida Anderson…
COVID-19 lit a fire under global regulatory systems, triggering regulatory bodies and pharma…
Humanity will reach a critical milestone when we can rapidly reprogram and re-engineer biological…
Community-based partnerships are vital to successfully addressing long-standing inequities in the…
How can patient advocacy groups attract an early-stage company to develop technology for their…
3:45 PM - 4:00 PM
We are advancing mRNA Lightning, a novel platform for the discovery of small molecule mRNA drugs…
Session Room 104A
Privately held and financed start up company focused on discovery and development of small…
Session Room 103
Mediphage, a preclinical-stage biotechnology company, is developing a next-generation non-viral…
Session Room 104B
Unravel Biosciences is the first rapid prototyping therapeutics company leveraging AI models of…
Session Room 104C
Vietnam's biopharmaceutical sector is one of the highest growth markets in the Asia Pacific region,…
Session Room 102B
4:00 PM - 4:15 PM
Accelerated Biosciences discovered and has freedom-to-operate to the Human Trophoblast Stem Cell …
Session Room 104B
Actinogen is an ASX-listed, biotech company conducting Ph 2 trials of an oral, brain-penetrant…
Session Room 103
The Asahi Kasei Group operates in the three business sectors of Material, Homes, and Health Care…
Session Room 104C
HAII is one of the most innovative digital therapeutics companies in South Korea. HAII was founded…
Session Room 104A
4:15 PM - 4:30 PM
The BioRankings team brings decades of experience working with data in diverse subject areas in…
Session Room 104A
CCPIT, the China Council for the Promotion of International Trade, is one of the largest trade and…
Session Room 102B
Chimeric Therapeutics is a clinical stage cell therapy company with encouraging early clinical data…
Session Room 104B
Clinical Stage Neuro Biotechnology company bringing science to Psilocybin to help people raise…
Session Room 103
Shaperon is a clinical stage biotech company developing novel inflammasome inhibitors(small…
Session Room 104C
4:30 PM - 4:45 PM
NEUROBIOGEN prioritizes its research and development efforts to develop innovative new medicine to…
Session Room 103
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing…
Session Room 104B
Reveal is a clinical stage company positioned to transform medical insight. Our first in class…
Session Room 104A
Rise Therapeutics is a clinical-stage developer of targeted oral immunotherapy drugs that leverages…
Session Room 104C
4:45 PM - 5:00 PM
Abu Dhabi’s Life-Science Sector Overview
The presentation will provide an overview of Abu Dhabi…
Session Room 102B
Leveragen is a genetic engineering company with technologies designed to revolutionize the…
Session Room 104A
MirimGENE's target of focus includes WARS among human aminoacyl-tRNA synthetase (ARSs). WARS, …
Session Room 104C
Built on the groundbreaking immuno-neurology research of our scientific founder, Dr. Edgar Engleman…
Session Room 103
Zelluna is developing a unique and proprietary "off the shelf" cell therapy platform. The approach…
Session Room 104B
5:00 PM - 5:15 PM
AltruBio is a privately held, clinical stage biotechnology company headquartered in San Francisco,…
Session Room 104C
An Overview of Japan's Life Science and Bio-Medical Ecosystem
Session Room 102B
NurrOn Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing…
Session Room 103
Protalix is a biopharmaceutical company focused on the development, production and…
Session Room 104B
5:15 PM - 5:30 PM
AMPEL BioSolutions is a precision medicine company commercializing a development pipeline of CLIA…
Session Room 104C
Curate Biosciences is a life science company offering what standard cell processing technologies…
Session Room 104A
At Ferrer we want to promote a new way of doing business and a responsible way of being in the…
Session Room 103
Forge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics…
Session Room 104B
7:00 PM - 9:00 PM
This event is open to Premier and General Access registrants only. These events are first come…
Big Night Live
Tuesday, June 6
6:30 AM - 6:00 PM
9:00 AM - 10:30 AM
Don't miss world-famous journalist, Katie Couric as she shares her work with Stand Up to Cancer in…
Main Stage, Ballroom
10:00 AM - 5:00 PM
Exhibition Floor
10:30 AM - 12:30 PM
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1…
Session Rooms 103-104C
10:30 AM - 10:45 AM
Cellular therapies, in which living cells are the drug administered to patients, have the potential…
Session Room 103
Demeetra’s proprietary gene editing technologies are being applied to unique biomanufacturing…
Session Room 104A
Fitabeo Therapeutics is a specialty pharmaceutical company, developing a diversified portfolio of…
Session Room 104C
ICEX Spain Trade and Investment is a public business organization that promotes the…
Session Room 102B
Sur180 Therapeutics is changing the way endometriosis pain and progression are treated. We are re…
Session Room 104B
10:45 AM - 11:00 AM
Code Bio is developing transformational, non-viral, genetic medicines to treat and potentially cure…
Session Room 103
Dignify Therapeutics is focused on restoring voluntary control of bowel and bladder function, with…
Session Room 104A
Plakous is a biotherapeutic company developing a patented platform that, in preclinical studies,…
Session Room 104C
No new mechanism to treat pain has been developed in the last 30 years. We must treat pain; a…
Session Room 104B
This presentation will showcase related facts that Taiwan is an “Ideal Partner for Precision Health…
Session Room 102B
10:45 AM - 11:30 AM
Join us for a hybrid discussion with the directors of the Center for Drug Evaluation and Research …
Session Room 205ABC
11:00 AM - 1:00 PM
We, ARCE Therapeutics, Inc., specialize in developing first and best-in-class gene-modified…
North Lobby
Ardan Pharma is an academic spin off company, investigating one guilty molecule of checkpoint…
North Lobby
Asgard Therapeutics is a Swedish private biotech company advancing cancer immunotherapies by…
North Lobby
Genius owns self-invented ultrasonic & AI technologies and provides innovative medical devices,…
North Lobby
Gilboa is a preclinical-stage biopharmaceutical company, co-located in Boston and Israel, that is…
North Lobby
Moleculex has created the world's first "intraoral" wound dressing to treat severe oral ulcers…
North Lobby
At Promakhos Therapeutics, we create therapies for autoinflammatory diseases based on a new and…
North Lobby
Saros Therapeutics is developing an innate immune activation technology for oncology. While…
North Lobby
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key…
North Lobby
Swaza is developing the first nanofluid breathing aid to treat acute oxygen loss. Our vision is to…
North Lobby
11:00 AM - 11:15 AM
Development-stage company developing first-in-class therapeutics for the treatment of chronic…
Session Room 104A
The Argentine biotechnology sector, which today is estimated at more than 300 companies and 54…
Session Room 102B
Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered,…
Session Room 104C
All cells respond to unique mechanical stimuli. Lahara Bio is an early-stage biotechnology company…
Session Room 103
Sustained Therapeutics is a clinical stage company developing non-opioid medicines for the…
Session Room 104B
11:00 AM - 12:00 PM
Biotech is a cornerstone to serving the world’s health-related needs for all demographics; but in…
Determining Value: Perspectives on Value Assessments, Value Calculations, and a Discussion of Ways…
The advent of mRNA vaccines, accelerated by the global SARS-Cov-2 pandemic, marked the beginning of…
An inspirational conversation about what’s next for biotech as we strive to get ahead of disease in…
Session Room 253ABC
The 33rd edition of EY’s Beyond Borders Biotechnology Report offers a chance to take stock of the…
Capital is a critical component for success. Although digital health funding dipped from its peak…
This session will engage an expert panel in a discussion on a number of timely regulatory policy…
Organizations from pharma sponsors, site networks, technology and service providers, advocacy…
Protecting Trade Secrets from the Growing Foreign Influence Threat to Early Stage Discovery Programs
The early discovery stages of the research and development process is the most vulnerable time for…
Over the last decade, there has been an incredible surge in innovation in the life sciences,…
The COVID-19 pandemic highlighted the need for more geographic diversity in the production…
11:00 AM - 5:30 PM
Nature’s Building Blocks: Diversity & Equity
• Why participation in clinical trials matters
•…
Session Room 105
11:15 AM - 11:30 AM
Adiso Therapeutics, Inc. is an innovative, private, clinical-stage biopharmaceutical company…
Session Room 104C
The Argentine biotechnology sector, which today is estimated at more than 300 companies and 54…
Session Room 102B
Vision: Expand patient access to therapeutic biologics with oral biologics in a pill modality.
…
Session Room 104A
Vybion is a virtual gene therapy company with Orphan Designation from the FDA for a Huntington's…
Session Room 103
11:15 AM - 11:45 AM
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in…
Session Room 104B
11:30 AM - 11:45 AM
Based in Houston, FibroBiologics is a regenerative medicine company developing a pipeline of…
Session Room 104A
Garuda is developing the world’s first, off-the-shelf hematopoietic stem cell platform that will…
Session Room 103
Merck has a strong history of success in translating cutting-edge research into life-saving medical…
Session Room 104B
SynAct Pharma AB is a clinical stage biotechnology company focused on the resolution of…
Session Room 104C
Session Room 102B
11:45 AM - 12:00 PM
The EIC is Europe’s flagship innovation program to identify, develop and scale up breakthrough…
Session Room 102B
First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development…
Session Room 104A
Morphocell Technologies is a regenerative medicine company developing an extensive therapeutic…
Session Room 103
Paradigm Biopharmaceuticals Ltd. (ASX:PAR) is a late-stage drug development company driven by a…
Session Room 104C
12:00 PM - 12:15 PM
Daré Bioscience is a biopharmaceutical company committed to advancing innovative products for women…
Session Room 104C
Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most…
Session Room 104B
Intract is a oral biologics drug delivery platform company focusing on lower gastrointestinal tract…
Session Room 104A
Presenting the the dynamic Italian Life Sciences Industry ecosystem and its Investiments…
Session Room 102B
Outpace is pioneering the era of curative cell therapies using protein design and cellular…
Session Room 103
12:15 PM - 12:30 PM
AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of…
Session Room 103
Mucommune is a privately-held startup focused on women's reproductive health. The lead product…
Session Room 104C
NIBEC is established as a spin-off venture from Seoul National University, South Korea at 2004 and…
Session Room 104A
12:15 PM - 1:30 PM
Christopher A. Viehbacher joined Biogen as President and Chief Executive Officer and a member of…
1:30 PM - 4:00 PM
BioProcess Insider Daily Interviews
1:30 – 1:45 PM Darren Head, CEO, Bionova Scientific
2:05–…
BioProcess Theater
1:45 PM - 2:45 PM
2023 marks the 40th anniversary of the Orphan Drug Act (ODA). Many advances have been made in the…
The Asia-Pacific region outside of Greater China now holds around a quarter of all the world’s new…
The value of biotech companies can best be described as a discontinuous growth function with…
Inequities exist at every phase of the U.S. healthcare system — from clinical research to diagnosis…
The COVID-19 pandemic significantly changed the RNA landscape, with new and exciting technologies…
FDA and sponsors share the goal of productive and timely engagement during drug development. …
Join us for this exciting Fireside Chat with Frank Nestle, Global Head of Research and Chief…
Session Room 205ABC
A closer look at current legislative initiatives being considered by the Senate Judiciary…
An aggressive drop in the market and the aftermath of two years of deals via Zoom create a unique…
Commitments to diversity, equity, and inclusion in the boardroom have been a priority in the…
Join a distinguished panel of international data privacy & data security experts for the latest…
1:45 PM - 5:00 PM
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1…
Session Rooms 103-104C
1:45 PM - 2:00 PM
DNASTAR is a leader in developing innovative software for comprehensive sequence assembly and…
Session Room 104A
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get…
Session Room 104B
Healx is an AI-powered techbio company redesigning drug discovery to develop treatments for rare…
Session Room 104C
Virtual Clinical stage (Phase 3 ready) Ophthalmology focused company with a lead molecule for…
Session Room 103
2:00 PM - 4:00 PM
48Hour Discovery (48HD) is a leading peptide-based platform accelerating discovery of novel…
North Lobby
Anticipate Bioscience is built on 5 years of world class medicinal chemistry by a veteran oncology…
North Lobby
Delymer - Novel polymer-based nanoparticles for targeted delivery and controlled release of gene…
North Lobby
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
North Lobby
MC Sciences is developing the Next Generation Therapeutics targeting mast cells. Based on the…
North Lobby
Mirscience is a biotech company that develop RNA therapy for the treatment of wasting muscle…
North Lobby
The Native Cell Membrane Nanoparticle (NCMN) system is GPCR targeted, detergent-free protein…
North Lobby
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key…
North Lobby
StemSight develops off-the-shelf regenerative cell therapies for corneal blindness using allogeneic…
North Lobby
T-E Meds, Inc. is a subsidiary company of T-E Pharma Holding which focuses on antibody-drug…
North Lobby
Zehna Therapeutics is developing non-bacteriocidal small molecule inhibitors of a specific gut…
North Lobby
2:00 PM - 2:15 PM
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine…
Session Room 104C
Novasenta is focused on the discovery of novel therapeutic targets to develop innovative and…
Session Room 103
SANOFI is an innovative global Healthcare company focused on human health.
We are an innovative…
Session Room 104B
SomaGenics, Inc. specializes in developing novel RNA-centered approaches to address unmet life…
Session Room 104A
2:15 PM - 2:30 PM
HTG is a platform-based drug discovery company using proprietary transcriptome-wide profiling and…
Session Room 103
Novartis provides healthcare solutions that improve and extend people’s lives. We use science-based…
Session Room 104B
ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave…
Session Room 104C
Redwire is at the forefront of biological and physical-science research in space. It has developed…
Session Room 104A
2:30 PM - 2:45 PM
DREAM Tech, LLC is a technology-based scientific consulting company specializing in providing…
Session Room 104A
PRG S&Tech is a Korean company specializing in R&D for rare genetic diseases founded in 2017, and…
Session Room 104C
Servier is an independent pharmaceutical company committed to therapeutic progress to serve patient…
Session Room 104B
Theranostec develops precision nanomedicines that significantly improve both the delivery and…
Session Room 103
2:45 PM - 3:00 PM
Session Room 104B
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and…
Session Room 104C
NuvOx is a Phase IIb platform biotech company. Focusing on reversing hypoxia (lack of oxygen), the…
Session Room 103
Vaxess Technologies is developing the MIMIX™ sustained release patch technology, the easiest and…
Session Room 104A
3:00 PM - 4:00 PM
Over the last 47 years, since the creation of the statutory regulatory framework, we’ve evolved…
While the biotech industry has seen record years of venture investment, crossover investments, and…
For many new therapies, Diversity, Equity, and Inclusion (DEI) is as much a commercial imperative…
The NIH estimates indicate that about 1 in 10 people in the United States have a rare disease, and…
This panel of top-tier biotech CEOs turned VC investors and advisors will discuss their outlook on…
The world is facing a demographic crisis, driven by unhealthy aging: societies across the globe are…
Cell therapies involve the use of living cells to treat or prevent disease. Cells are removed from…
As computational analysis and informatics play an increasingly important role in R&D, biopharma…
How have new understandings of cell biology, genomics, AI/ML based platform technologies expanded…
In the United States, there are two worldclass state-funded and voter approved biomedical research…
3:00 PM - 3:15 PM
Brinter is a BioTech/MedTech startup from the US and Finland. With our patented 3D (bio)printing…
Session Room 104A
Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with…
Session Room 104B
Osmol is a spin-out of Yale University developing a novel treatment, OSM-0205, to prevent…
Session Room 103
TAHO is a commercial-stage specialty pharma pioneering in oral, transdermal drug delivery systems. …
Session Room 104C
3:00 PM - 3:45 PM
Join us for this exciting Fireside Chat with Noubar Afeyan, CEO and Founder of Flagship Pioneering…
3:15 PM - 3:30 PM
AULBIO is a research-intensive biotechnology company located in Korea. It is engaged globally in…
Session Room 104C
Bridge Biotherapeutics Inc. is a publicly traded clinical-stage biotech company based in the…
Session Room 104B
Cellusion is a Japanese regenerative medicine start-up from Keio University, School of Medecine in…
Session Room 104A
As NCI SBIR Investor Initiative Awardee, we are leveraging a cutting-edge approach using…
Session Room 103
3:30 PM - 3:45 PM
Coagulant Therapeutics leverages nearly 100 years of industry experience in both Hematology and…
Session Room 104C
SIRPant Immunotherapeutics Inc. is focused on the development of novel autologous macrophage cell…
Session Room 103
Theradaptive was founded to give patients who have no good options a better choice. Through our…
Session Room 104A
Zambon Biotech is part of the Zambon group of companies, it is focused in growing the portfolio and…
Session Room 104B
3:45 PM - 4:00 PM
Baseimmune is a discovery stage biotech company developing future-proof antigens. Based on…
Session Room 104C
Fosun Pharma is a gloabl pharmaceutical company
that is patient-centered and clinical needs…
Session Room 104B
Pharos iBio is a clinical stage biotech company that develops novel drug for rare and refractory…
Session Room 103
Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative…
Session Room 104A
4:00 PM - 4:15 PM
Hello, we are a startup company established in National Cancer Center (NCC), Korea developing anti…
Session Room 103
PSC Biotech® has spent more than two decades providing life sciences with essential services and…
Session Room 104C
Rege Nephro is pre-clinical stage company developing a allogenic cell therapy by human iPS cell…
Session Room 104A
SPARK biopharma, Inc. is a clinical-stage drug discovery and development company pursuing…
Session Room 104B
4:00 PM - 5:15 PM
With every passing year, the life sciences industry leads new advancements and innovation with the…
4:15 PM - 5:15 PM
Representatives from the Committee on Foreign Investment in the United States (CFIUS) will speak to…
Let’s talk about all the good things and all the bad things that may be when it comes to realizing…
Though the life science industry has made strides in increasing diversity, equity and inclusion …
Data only has value when it is discoverable, shareable, and usable, but most rare disease data…
The Vaccines for Children (VFC) program was established in 1994 to increase access to childhood…
Join us for a robust discussion on the topic of International Regulatory Harmonization in our…
An increasingly vocal group of critics complain that life-sciences patents are holding up…
While academic scientists have always brought to light new insights, these have traditionally been…
4:15 PM - 4:30 PM
Our commercial flagship products Rexulti, Abilify Maintena, and Jynarque have established Otsuka as…
Session Room 104B
Panavance Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company developing a…
Session Room 103
Shanghai Novamab Biopharmaceuticals Co., Ltd is an innovative biopharmaceutical company dedicated…
Session Room 104C
Tonix is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines…
Session Room 104A
4:15 PM - 4:45 PM
David Thomas, BIO’s Senior Vice President of Industry Analysis, will provide an overview of recent…
4:30 PM - 4:45 PM
ADP provides an experienced and practical approach for guiding our engineering services clients…
Session Room 104A
Ceria Therapeutics is a preclinical biopharmaceutical company that develops drug products to treat…
Session Room 104C
Enveda’s novel, proprietary drug discovery platform uses machine learning, metabolomics, and…
Session Room 104B
Kernal Bio is a venture-backed biotech company developing mRNA 2.0 immunotherapies. Kernal Bio…
Session Room 103
4:45 PM - 5:00 PM
The Nikon BioImaging Lab in Cambridge, Massachusetts (USA) provides contract research services for…
Session Room 104A
Clinical stage company focusing on Radiopharmaceutical Imaging and Therapies in Oncology
Session Room 103
Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company focused on…
Session Room 104C
Zymeworks is a global biotechnology company developing novel, multifunctional therapeutics to…
Session Room 104B
5:00 PM - 6:30 PM
Explore the exhibit floor with special events, food, and drink presented by our incredible…
Exhibition Floor
Wednesday, June 7
6:30 AM - 6:00 PM
9:15 AM - 10:45 AM
FDA Commissioner Dr. Robert Califf will discuss the latest issues at the FDA, the use of technology…
Main Stage, Ballroom
10:00 AM - 6:00 PM
Exhibition Floor
10:30 AM - 10:45 AM
Combined Therapeutics Inc. (CTx) is a privately held biotechnology company developing the next…
Session Room 104B
Lynk Pharmaceuticals, a clinical-stage company with global locations, actively seeks new…
Session Room 103
Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce…
Session Room 104C
Peptilogics engineers peptide therapeutic candidates to radically improve the treatment landscape…
Session Room 104A
10:30 AM - 12:30 PM
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1…
Session Rooms 103-104C
10:45 AM - 12:00 PM
The success of the Accelerated Approval pathway has meant countless patients received access to…
Immune checkpoint inhibitors have changed the way we treat cancer patients. However, only a…
10:45 AM - 11:00 AM
Enquyst Technologies is an early-stage biotechnology company that is disrupting the way that…
Session Room 104C
IAMA Therapeutics is a Series A- late preclinical-stage pharmaceutical company focused on…
Session Room 104B
Micron Biomedical is a clinical stage company developing products that utilize a proprietary…
Session Room 103
A clinical stage, specialty pharmaceutical company with a disruptive anti-infective platform…
Session Room 104A
11:00 AM - 11:15 AM
Aruna’s AB126, a therapeutic exosome, is an innovative neural anti-inflammatory and neuromodulator…
Session Room 104B
o Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of…
Session Room 104A
Immunis Inc is a private biotechnology company developing a novel immunomodulatory secretome…
Session Room 104C
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing New Classes of Synthetic Anti…
Session Room 103
11:00 AM - 1:00 PM
AyuVis designs and develops novel, small molecule immunotherapies to prevent and treat inflammatory…
North Lobby
Azora Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule…
North Lobby
ElectraTect, Inc was founded in 2020 based on technology developed at the University of California,…
North Lobby
ImunoTera is a spin off from University of Sao Paulo (USP), considered the best university in
Latin…
North Lobby
Despite advances in surgical glues and hemostatic patches, 30-50% of surgeries still suffer from…
North Lobby
We're developing mitochondrial protective small molecules for epilepsy, Parkinson's and…
North Lobby
Paradox Immunotherapeutics is an orphan drug company that develops immunotherapies for protein…
North Lobby
Reference Medicine was founded to solve the problem of oncology diagnostic developers struggling to…
North Lobby
Reglagene is a therapeutics company transforming tubulin targeting therapy for brain diseases…
North Lobby
RT MicroDx is developing an easy-to-use, home diagnostic platform that detects bacterial or viral…
North Lobby
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key…
North Lobby
11:00 AM - 12:45 PM
11:00 – 11:20 AM Advancing Data Driven Drug Discovery
Letian Kuai, Vice President, Head of WuXi…
BioProcess Theater
11:00 AM - 12:00 PM
Join us for a special edition of the popular weekly discussion of all things biotech. Reporting…
With growing inflation and economic turmoil, budgets are tighter than ever. Governments and other…
Legislative advocacy is cornerstone to achieving impactful public policy. Many advocacy efforts are…
China’s urge for innovation is strong and has enabled some biotechs to develop first in class and…
The development of cell, gene therapy, and genome editing presents several challenges. While…
Ironically, billions of dollars and FOMO investor zeal frantically chasing the promise of…
The pandemic forced support ecosystems for emerging biotechs to adapt their processes to continue…
Navigating the Neurodegenerative Diseases Labyrinth: Perspectives from Academia, Biotech, and Pharma
Identifying effective treatments for neurodegenerative diseases is challenging given that the…
The Preparedness and Treatment Equity Coalition (PTEC) works across the healthcare sector to bring…
New viruses emerge with ever-increasing frequency; however, we still lack antiviral therapeutics…
11:00 AM - 5:30 PM
Nature’s Building Blocks: Patient Stories
• Haemophilia treatments across generations
• The…
Session Room 105
11:00 AM - 12:15 PM
Join us to learn about special programs and resources supporting career opportunities and…
Room 102B
11:15 AM - 11:30 AM
Alchemab has developed a highly differentiated platform which enables the identification of novel…
Session Room 104B
Matchstick’s premier product, PIXUL® (stands for PIXelated ULtrasound), is a sample preparation…
Session Room 104A
Mitotherapeutix is a preclinical stage pharmaceutical company that is focused on the development of…
Session Room 104C
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture…
Session Room 103
11:30 AM - 11:45 AM
CK Regeon (CKR) provides innovative approaches to develop novel small molecules which can treat…
Session Room 104C
IRR is a science-based drug development company focused on pharmaceutical products for the…
Session Room 104B
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose. …
Session Room 103
Progentec is committed to improving access and health outcomes for patients in therapeutic areas…
Session Room 104A
11:45 AM - 12:00 PM
Boehringer Ingelheim Animal Health is a global leader in animal health and part of the family-owned…
Session Room 103
MEPSGEN, a biotech company founded by Dr. YongTae Kim and Dr. Robert Langer in 2019, develops and…
Session Room 104B
- Mursla (Cambridge, UK) is an emergent techbio startup, leveraging extracellular vesicle biology…
Session Room 104A
Nanoscope Therapeutics is a late-stage clinical company developing an optogenetic platform to…
Session Room 104C
12:00 PM - 12:15 PM
Concarlo Therapeutics is a preclinical-stage oncology company developing transformative…
Session Room 104A
Energesis Pharmaceuticals is developing a new class of highly differentiated drugs that -- unlike…
Session Room 104C
Immuneering is a clinical-stage oncology company developing medicines for broad populations of…
Session Room 103
Muscle toning drug for multiple applications including sleep apnoea, cosmetics such as ectropion…
Session Room 104B
12:15 PM - 12:30 PM
Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and…
Session Room 104A
KAER focuses on high dose delivery of aerosolized drugs for serious and life-threatening…
Session Room 103
OncoHost is a commercial-stage precision oncology company headquartered in Binyamina, Israel, and…
Session Room 104B
Presentation Description: Phanes Biotech is a biotech company developing novel therapies for the…
Session Room 104C
12:15 PM - 1:30 PM
Realizing the Promise of Gene Therapy and Gene Editing: Current Challenges, Opportunities and Trends
Genetic therapies are transforming patients’ lives in ways unimaginable 20 years ago, and recent…
1:00 PM - 2:45 PM
1:00 - 1:20 PM
Enabling and Accelerating Targeted Protein Degraders and Molecular Glues Drug…
BioProcess Theater
1:45 PM - 2:45 PM
The Inflation Reduction Act (IRA) contains some of the most significant changes to prescription…
While research shows that diverse teams perform better, are more creative, and contribute to higher…
The coming wave of gene therapies has already forced biotechs to change their development model…
mThe discovery of antibiotics was one of the biggest medical breakthroughs in the 20th century and…
The human genome contains approximately 30,000 genes. Of these, 6,000+ sites are estimated to have…
The psychedelics industry has evolved from a stigmatized counterculture to a scientifically robust…
This session will review exciting developments in cloud-based submissions which are now a reality…
An alarm is being sounded by patients, caregivers, and providers around the high acuity of distress…
Despite recent strides in medical innovation – in oncology, COVID-19, neurodegenerative disorders…
1:45 PM - 2:00 PM
Baiya Phytopharm is an Asia based biotech company established by a global leader in plant-based…
Session Room 103
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop…
Session Room 104B
Enterome is a clinical stage company developing off-the-shelf, transformational cancer treatments…
Session Room 104A
Sinopia Biosciences is a biotechnology company leveraging a multi-omics powered AI/ML drug…
Session Room 104C
1:45 PM - 5:00 PM
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1…
Session Rooms 103-104C
2:00 PM - 4:00 PM
ARIZ Precision Medicine (pronounced “Arise”) is developing first in class cancer therapeutics based…
North Lobby
CorriXR Therapeutics is an oncology-focused biotherapeutics development company enabled by a novel…
North Lobby
Cyta Therapeutics is a pre-clinical company developing therapies for cardiometabolic diseases…
North Lobby
FAKnostics is a dynamic pharmaceutical and diagnostics company, developing next generation drugs…
North Lobby
Grannus Therapeutics is a pre-clinical platform company focused on developing and commercializing…
North Lobby
Guardian Bio is a cancer therapeutics platform creating the next generation of cell therapies to…
North Lobby
LASE Innovation is an early-stage company based near Boston, MA that is focused on solving complex…
North Lobby
March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient…
North Lobby
MelliCell is a pre-clinical biotechnology company with innovative technology to develop…
North Lobby
OmniCyte is a preclinical Immunology company. Our therapeutics are developed on our proprietary,…
North Lobby
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key…
North Lobby
2:00 PM - 2:15 PM
Galapagos is a fully integrated biotechnology company focused on discovering, developing and…
Session Room 104A
ImmunoChem Therapeutics, a Phase 2 clinical stage, Northwestern University spin-out, is developing…
Session Room 104C
Synaffix BV is a biotech company that has established a proprietary, clinical-stage technology…
Session Room 103
2:15 PM - 2:30 PM
Atomic AI is an emerging biotechnology company exploiting the fusion of artificial intelligence and…
Session Room 103
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for…
Session Room 104B
Courage Therapeutics is a pre-clinical biotech company focused on feeding behavior. The company has…
Session Room 104C
MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of…
Session Room 104A
2:30 PM - 2:45 PM
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company,…
Session Room 104B
Sensei Biotherapeutics (NASDAQ: SNSE) is an immuno-oncology company focused on the discovery and…
Session Room 104A
Synthego was founded to revolutionize genome engineering technology, helping translate genomics…
Session Room 103
Vincere Biosciences is developing AI-derived mitochondrial targeted therapeutics with a mission to…
Session Room 104C
2:45 PM - 3:00 PM
Algen is a platform therapeutics and drug discovery company using the world’s leading CRISPR and AI…
Session Room 103
IMUNON is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio…
Session Room 104A
Navigo Proteins is a fast-growing German biotech developing next-generation targeted therapeutics,…
Session Room 104B
Praxis Bioresearch is an NIH Innovation Zone Company developing a novel treatment for behavioral…
Session Room 104C
3:00 PM - 4:00 PM
Are AI-enabled solutions advancing quickly enough to outpace the rapidly evolving mental health…
Academic developers are major contributors to the research and development of cell and gene…
This panel will present comparative views of biopharma, investor-backed, and independent incubators…
This session will be based on LHS’ trademarked process of creating corporate narratives and…
The Asia Pacific (APAC) region has become an increasingly attractive location for investments in…
Each year the National Institutes of Health's (NIH) various institutes award over $1.2 billion in…
Hear how leading science and tech companies are combining their unique strengths to discover and…
Respiratory Syncytial Virus (RSV) has long been a global public health focus, representing a…
Hear from leading patient advocates and policy experts on IRA implementation from the patient and…
This panel will discuss the evolving landscape of immunotherapy in solid tumors, with a focus on…
This panel will focus on the unique voice that the life sciences industry can bring to the table in…
Session Room 210A
3:00 PM - 3:15 PM
Affivant is a Basel, Switzerland based biotech company developing innate immune cell engagers for…
Session Room 104B
Lokon Pharma is a privately owned, Swedish biotech company developing immunostimulatory gene…
Session Room 104A
Guangzhou Magpie Pharmaceuticals, Inc. (MPI) is a clinical stage drug discovery and development…
Session Room 103
St. Jude Children's Research Hospital is a non-profit pediatric research institution. The mission…
Session Room 104C
3:15 PM - 3:30 PM
Macro Biologics’ innovative technology platform creates synthetic biological polymers (macro…
Session Room 104C
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next…
Session Room 103
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision,…
Session Room 104A
Solaxa is a clinical-stage, bio-pharmaceutical, start-up company developing and commercializing…
Session Room 104B
3:30 PM - 3:45 PM
EmendoBio is a gene editing company with a diverse therapeutic pipeline based on proprietary…
Session Room 103
We are a clinical-stage biopharmaceutical company focused on the development of GP2, an…
Session Room 104A
MicuRx was founded by Dr. Zhengyu Yuan and Dr. Mikhail F. Gordeev, and is led by an experienced,…
Session Room 104B
We are an innovative biopharmaceutical company developing and commercializing a pipeline of drug…
Session Room 104C
3:45 PM - 4:00 PM
Cartherics is an Australian biotech company developing a range of allogeneic (off-the-shelf) immune…
Session Room 103
Kintara Therapeutics is a clinical stage drug development company with a focus on the development…
Session Room 104A
SAB Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of…
Session Room 104B
3:45 PM - 4:30 PM
LinusBio is a patient-centric, precision exposome medicine company, originating from the world’s…
Session Room 104C
4:00 PM - 4:15 PM
Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop…
Session Room 104B
Bolden Therapeutics is a preclinical-stage biotechnology company developing first-in-class…
Session Room 104C
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to…
Session Room 104A
RheumaGen is developing a novel gene-editing therapy to cure rheumatoid arthritis (RA). RheumaGen’s…
Session Room 103
4:00 PM - 5:15 PM
Innovation. Which ideas and inventions are likely to serve as the foundation for the creation of…
4:15 PM - 4:30 PM
Arpeggio makes medicine to alter gene expression and fight drug resistance in cancer. We do this by…
Session Room 104B
ArtisanBio provides premiere genome engineering tools for cell and gene therapy companies looking…
Session Room 103
Genesis Therapeutics has created the industry's most advanced molecular AI platform by combining…
Session Room 104C
Like real-time traffic data revolutionized how we drive, Pepper Bio, the world’s first transomics…
Session Room 104A
4:15 PM - 5:15 PM
As more and more diverse cell therapies are progressing through the pipeline, innovators are…
Leveraging biotechnology innovation will be key to meeting global efforts to combat climate change…
FDA’s Oncology Center of Excellence launched “Project Optimus” in 2021, to encourage sponsors to…
Early to Mid-Stage Biotechs: Creating Partnerships to Enhance Program Value and Accelerate Therapies
Moderated by Drew Armstrong of Endpoints News, this interactive panel discussion aimed at early to…
What do biotech companies need to consider as they develop their global growth strategy? Companies…
COVID-19 is here to stay. With current prevention and treatment strategies, the virus will continue…
The IRA is market-driven. It is changing the US healthcare landscape with new approaches toward…
Brain aging drives devastating neurodegenerative diseases including Alzheimer’s and Parkinson’s,…
4:30 PM - 4:45 PM
At Avstera, our primary focus is to address the significant unmet need of cancer patients failing…
Session Room 104B
CancerFree Biotech is a start-up company dedicated to personalized treatment of cancer.
We…
Session Room 104A
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
Session Room 104C
Umoja Biopharma, Inc. is a transformative in vivo CAR T and immuno-oncology company creating…
Session Room 103
4:45 PM - 5:00 PM
Accession Therapeutics is developing a new generation of immunotherapies for solid tumors.
…
Session Room 104B
AI Proteins is re-imagining the possibilities of protein therapeutics by rationally designing…
Session Room 104C
NeoImmuneTech (NIT) is a T-cell Centric IO Company and the Global Leader in Interleukin (IL-7). At…
Session Room 104A
ViGeneron is based on our passion to deliver gene therapy innovations and advances to people in…
Session Room 103
7:00 PM - 9:00 PM
This event is open to Premier and General Access registrants only. These events are first come…
MGM Music Hall at Fenway
Thursday, June 8
6:30 AM - 4:30 PM
9:00 AM - 10:00 AM
The use of patient experience data (PED) to inform the development and benefit-risk assessment of…
Join us for a captivating Fireside Chat session where we'll have the privilege of hosting the…
Tackling a problem like cancer requires both the ingenuity of small biotech players and the…
Companies are using AI/ML models to make pre-clinical drug development a more streamlined process…
While often evaluated by the modality they employ or therapeutic area in which they focus, a…
The pharma pipeline is brimming with ever more personalized therapies, mutation-specific…
The Cancer Moonshot in Africa: Improving Cancer Patient Outcomes through Public-Private Partnerships
During the recent U.S.-Africa Leaders Summit in December 2022, First Lady Dr. Jill Biden recognized…
Genome Editing therapeutic platforms (e.g. zinc finger nucleases, TALENs, meganucleases) have…
9:00 AM - 2:30 PM
Nature’s Building Blocks: Spotlighting Discoveries
• The therapies made from synthetic DNA
•…
Session Room 105
10:00 AM - 4:30 PM
Exhibition Floor
10:15 AM - 11:15 AM
More than 10 years ago, the first immune checkpoint inhibitor (ICI) was approved in a monumental…
Cardiovascular disease is the leading public health issue in the United States, according to the…
Major changes in the diagnostics industry are underway with an increased push to self-testing,…
Next-generation approaches to gene therapy are emerging as one of the most promising areas of drug…
Vaccines are global health’s biggest success, helping people of all ages live longer, healthier…
Health systems are not only the source of scientific innovation that leads to new treatments for…
10:30 AM - 1:00 PM
View 13-minute podium presentations across a wide range of therapeutic areas. Join us on Level 1…
Session Rooms 103-104C
10:30 AM - 10:45 AM
Covant’s mission is to treat diseases with transformative therapeutics using covalency to modulate…
Session Room 104A
Modulus Discovery, Inc., is a pre-clinical stage biotechnology company with a cutting-edge…
Session Room 103
10:45 AM - 11:00 AM
Ethris mission is to redefine mRNA medicines through best-in-industry delivery, stability,and…
Session Room 103
Sarcomatrix is a pre-clinical biotech developing first-in-class drugs to treat muscle wasting…
Session Room 104A
11:00 AM - 1:00 PM
AnHorn Medicines is a drug discovery platform company with a strong pipeline, offering therapies…
North Lobby
Clinials is an AI driven participant recruitment platform, solving the problem where 80% of…
North Lobby
Enquyst Technologies is on a quest to engineer next-generation biomanufacturing technology…
North Lobby
Immuto Scientific is on a mission to drug the 'undruggable'. We enable the discovery of first-in…
North Lobby
pacDNA is transforming the field of gene regulation therapeutics with our proprietary Brushield™…
North Lobby
Phase 3 ready rare disease company focused on MCT8 deficiency (a.k.a. Allan-Herndon Dudley Syndrome…
North Lobby
ReNewVax has developed a vaccine discovery platform based on the exploitation of genomic analysis…
North Lobby
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key…
North Lobby
VaxSyna, inc. is a pre-clinical vaccine company that is creating room-temperature stable vaccines…
North Lobby
11:00 AM - 11:15 AM
ITabMed Ltd. is a clinical-stage biotech company developing immunotherapy antibodies (ITAbTM) to…
Session Room 103
Novelna Inc. is a biotech start-up, pioneering accurate and affordable screening tests for early…
Session Room 104A
11:15 AM - 11:30 AM
Cyrus Biotechnology is a pre-clinical-stage biotech company combining computational protein
…
Session Room 104A
KaliVir Immunotherapeutics is a private biotechnology company dedicated to developing systemically…
Session Room 103
11:30 AM - 11:45 AM
PeptiDream Inc. (Tokyo Stock Exchange: 4587) is leading the translation of macrocyclic peptides…
Session Room 104A
Phanes is a clinical stage biotech focused on innovative drug discovery and development in oncology…
Session Room 103
11:45 AM - 12:00 PM
Clinical-stage biopharmaceutical company developing therapeutics for the treatment of central…
Session Room 104A
Founded in 2014, XtalPi founders recognized a common hurdle in drug development having to do with…
Session Room 103
12:00 PM - 12:15 PM
BIORCHESTRA is a biotherapeutics company focused on degenerative and rare Central Nervous System …
Session Room 104A
FivepHusion is an advanced clinical stage biotech company developing Deflexifol™, a novel enhanced…
Session Room 103
12:15 PM - 12:30 PM
Basgenbio is a clinico-genomic cohort-based R&D company with K-Biobank, which contains blood…
Session Room 103
12:15 PM - 1:00 PM
Protibea is a clinical stage company whose product has been dosed in 200+ patients for up to one…
Session Room 104A
12:30 PM - 12:45 PM
Henlius is a global biopharmaceutical company with the vision to offer high-quality, affordable,…
Session Room 103
Precision NanoSystems, now part of the Danaher Life Sciences platform, is a global leader in…
Session Room 104A
12:45 PM - 1:00 PM
Co-founded by Professor Junying Yuan and Professor Jidong Zhu, two leading scientists in cell death…
Session Room 103
TiCARos is developing very differentiated CAR-T based on our proprietary CAR-T construct designing…
Session Room 104A
1:00 PM - 2:00 PM
In vitro diagnostics have seen incredible innovation during the COVID-19 pandemic, and advances in…
Panelists will discuss how to rethink innovation in oncology. Experts will touch on global patient…
In 2020, more than 71% of those with PhDs in health and medical sciences were women, strategically…
1:30 PM - 3:00 PM
Raise a glass to another successful year at the BIO International Convention and help us build…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
